Veru is a biopharmaceutical company that specializes in developing novel medicines.
Veru has raised $25.2M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in October 2025.
Veru is headquartered in Miami, United States.
Veru is a biopharmaceutical company that specializes in developing novel medicines.
Veru is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Veru — Funding & Investors." VCBacked, October 30, 2025, https://www.vcbacked.co/company/veru. Accessed August 15, 2026.
VCBacked. (2025). Veru — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/veru
{{cite web |title=Veru — Funding & Investors |url=https://www.vcbacked.co/company/veru |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated